IDI (LON:0I0P)
72.40
0.00 (0.00%)
At close: Oct 15, 2025
IDI Revenue
IDI had revenue of 14.07M EUR in the quarter ending June 30, 2025, with 115.32% growth. This brings the company's revenue in the last twelve months to 50.12M, up 284.82% year-over-year. In the year 2024, IDI had annual revenue of 35.05M, down -60.83%.
Revenue (ttm)
50.12M EUR
Revenue Growth
+284.82%
P/S Ratio
10.54
Revenue / Employee
1.04M EUR
Employees
48
Market Cap
452.84M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.05M | -54.44M | -60.83% |
| Dec 31, 2023 | 89.49M | -4.68M | -4.97% |
| Dec 31, 2022 | 94.17M | -52.02M | -35.59% |
| Dec 31, 2021 | 146.19M | 102.98M | 238.35% |
| Dec 31, 2020 | 43.21M | -6.59M | -13.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |